Saline Sonography vs Hysteroscopy Before IVF: Which Test?

Saline infusion sonography, sometimes called SIS or sonohysterography, distends the uterine cavity with sterile fluid during ultrasound. It can help identify suspected polyps, cavity-distorting fibroids or adhesions. It is an examination requiring appropriate equipment and infection precautions, not a blood test. Timing and pregnancy exclusion are important, and your clinician will explain discomfort, infection risk and preparation.

Hysteroscopy introduces a camera through the cervix so the clinician can inspect the endometrium directly. In selected cases, tissue sampling or treatment of a confirmed lesion may be possible. Diagnostic and operative hysteroscopy differ in preparation, equipment, risks and cost. Not every minor image finding requires surgery, so ask what diagnosis is suspected before booking an operative procedure.

If initial ultrasound and clinical assessment are reassuring, a fertility specialist may not recommend invasive investigation before a first IVF cycle. Symptoms such as unusual bleeding, prior uterine surgery, repeated pregnancy losses or a suspected cavity lesion can change the threshold for further assessment. Guidelines discourage indiscriminate testing that has little chance of changing care. The aim is to investigate a real question, not obtain a longer list of reports.

An ultrasound image that suggests a polyp is a specific anatomical question; a request for an expensive “receptivity” add-on without an identified concern is a different proposition. Ask the clinician to show which image or symptom prompts the cavity investigation and what happens after a normal result. Additional tests are most helpful when they lead to a justified change in treatment, not when they simply increase the number of tests performed.

A uterine-cavity investigation may be scheduled at a different time from stimulation or embryo transfer. If a lesion needs treatment, discuss how healing and follow-up will affect any planned frozen transfer. Separately, ask whether infection testing, pregnancy exclusion or anaesthesia assessment is needed. There is no useful universal promise about how quickly everyone returns to treatment.

Ask which test is less invasive for the suspected abnormality, whether the cheaper test could lead to a second procedure and what an abnormal finding would trigger. Request an itemised estimate of imaging, procedure, pathology and anaesthesia where relevant. A high-quality consultation should explain why one option is sufficient or why direct visual assessment is preferable for your individual circumstances.

Before either test, clinicians may ask about bleeding, pregnancy possibility, infection symptoms and relevant allergies. Discuss pain-control options, whether antibiotics are clinically indicated and what to expect afterward. If hysteroscopy might become operative, consent should make clear which treatments may be performed and what requires separate discussion. A patient should know whom to contact for fever, persistent worsening pain or heavy bleeding following a procedure.

HomeIVF is a doctor-led fertility-care model intended to reduce unnecessary visits, not to relocate IVF procedures into a residence. Depending on the individual plan and the service confirmed at an address, care may include teleconsultation, selected home blood collection or appropriately supervised injection support. The prescribing doctor must review monitoring and medicines. Ultrasound scans when required, egg retrieval, sperm preparation, embryology and embryo transfer need appropriately equipped medical facilities. Ask the team to identify which stage they can actually support, who is responsible, and where every non-home procedure will occur.

Ask your team to issue a concise written pathway: what the diagnosis is, which tests are still needed, which appointment is time-sensitive, and who signs off treatment changes. If costs are relevant, separate required treatment from optional additions and future storage or transfer fees. When more than one provider participates, request a single point of medical accountability. An organised handover is especially valuable if travel or work prevents frequent unscheduled visits.

Online information can help prepare questions but cannot determine whether a symptom requires a scan, a changed prescription or urgent examination. If you develop sudden severe pain, faintness, significant bleeding, breathlessness or another alarming symptom, use emergency medical services and inform the fertility team. Keep the phone number of the actual treating facility. A home-support promise is not a substitute for an emergency referral arrangement.

Treatment should fit the clinical indication and your circumstances, not the other way around. Bring questions, request itemised costs where appropriate, and obtain the location and responsible clinician for each facility-based step. Use remote and home-supported options where genuinely available without compromising medical assessment or laboratory standards.